Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2019-03-31
2020-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Microbiome Test for the Detection of Colorectal Polyps and Cancer
NCT02141945
Protocol to Validate the Performance of the LifeKit® Prevent Colorectal Neoplasia Test for CRC Screening
NCT04693546
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
NCT03789162
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas
NCT00843375
Development and Validation of Metabolic Biomarkers for Early Diagnosis, Prognosis, and Recurrence of Colorectal Cancer：MetBio-CRC
NCT07068529
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Diagnosed colon cancer patients
Patients undergoing colectomy for colonic adenocarcinoma.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female,
* Age: 18-95 years,
* Able to comprehend, sign, and date the written informed consent form (ICF),
* Able to give informed consent in English
* Women and minorities will be included.
Exclusion Criteria
* Antibiotics within 2 weeks of sample collection.
* Colonoscopy, colon prep or bowel contrast agent within 7 days prior to sample collection
* Any radiation therapy
18 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Metabiomics Corp
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jon Vogel, MD
Role: PRINCIPAL_INVESTIGATOR
University of Colorado School of Medicine Anschutz Medical Campus
Christopher Lieu, MD
Role: PRINCIPAL_INVESTIGATOR
University of Colorado School of Medicine Anschutz Medical Campus
Patrick Gillevet, PhD
Role: PRINCIPAL_INVESTIGATOR
George Mason University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Colorado School of Medicine Anschutz Medical Campus
Aurora, Colorado, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MB-02_CU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.